Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Kaempferol and Doxorubicin Hydrochloride

Research Papers that Mention the Interaction

In vitro, Lu at dose less than 100 microM had only slight effect on cells growth and cytotoxicity of Dox in 4T1 and MCF-7 cells under normoxia, but it could reverse tumor resistance to Dox and promote death of tumor cells under hypoxia.
Biochemical and biophysical research communications  •  2008  |  View Paper
Focusing on the proliferative effect at low concentrations, we showed that luteolin has a cytoprotective effect on MCF-7 cells when administered with doxorubicin.
Moreover, luteolin attenuated doxorubicin-induced cytotoxicity even in the presence of the estrogen receptor (ER) antagonist ICI 182,780 and the ER-negative MDA-MB-453 human breast cancer cell line.
Biological & pharmaceutical bulletin  •  2015  |  View Paper
At physiological concentrations, luteolin significantly sensitized A549 cells to the anticancer drugs oxaliplatin, bleomycin, and doxorubicin.
Free radical biology & medicine  •  2011  |  View Paper
Because the toxic effect of both kaempferol and doxorubicin was amplified when used in combination, this study raises the possibility of combinatorial therapy whose basis constitutes enhancing redox perturbation as a strategy to kill glioma cells. [
Importantly, kaempferol potentiated the toxic effect of chemotherapeutic agent doxorubicin by amplifying ROS toxicity and decreasing the efflux of doxorubicin.
Molecular Cancer Therapeutics  •  2007  |  View Paper
Three inhibitors of tyrosine kinases (genistein, kaempferol , and quercetin) can inhibit the in vitro generation of ADR activity.
Experimental cell research  •  1993  |  View Paper
The combination of alpha G-Rutin and luteolin with DOX significantly inhibited the DOX induced-increment of the lipid peroxide level in bone marrow cells.
Toxicology letters  •  1997  |  View Paper
The combination of KF and doxorubicin revealed a stronger inhibitive effect on the viability of liver cancer cells.
Oncology reports  •  2021  |  View Paper
Therefore, luteolin can act as a chemoprotective agent in abating toxicities associated with doxorubicin usage and improve its therapeutic efficacy.
Human & experimental toxicology  •  2021  |  View Paper
LUT inhibited the activity of phlpp1 leading to positive regulation of the AKT/Bcl-2 pathway, which attenuated doxorubicin-induced cardiotoxicity.
PeerJ  •  2020  |  View Paper
Furthermore, luteolin attenuated doxorubicin-induced cardiotoxicity through promoting mitochondrial autophagy in association with facilitating phosphorylation of Drp1 at Ser616, and upregulating TFEB expression.
Frontiers in Physiology  •  2020  |  View Paper
Show More